Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Fiscal Year Ending March 31, 2024
August 04, 2023 at 12:00 am EDT
Share
Toho Holdings Co., Ltd. provided consolidated earnings guidance for the six months ending September 2023 and fiscal year ending March 31, 2024. For the six months, net sales to be JPY 651,000 million, operating profit to be JPY 3,800 million, profit attributable to owners of parent to be JPY 6,700 million and basic earnings per share to be JPY 102.38.
For the fiscal year, net sales to be JPY 1,325,000 million, operating profit to be JPY 11,500 million, profit attributable to owners of parent to be JPY 12,300 million and basic earnings per share to be JPY 189.15.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
